These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 14512309)
1. In vitro and in vivo effects of tPA and PAI-1 on blood vessel tone. Nassar T; Akkawi S; Shina A; Haj-Yehia A; Bdeir K; Tarshis M; Heyman SN; Higazi AA Blood; 2004 Feb; 103(3):897-902. PubMed ID: 14512309 [TBL] [Abstract][Full Text] [Related]
2. The fibrinolytic system attenuates vascular tone: effects of tissue plasminogen activator (tPA) and aminocaproic acid on renal microcirculation. Heyman SN; Hanna Z; Nassar T; Shina A; Akkawi S; Goldfarb M; Rosen S; Higazi AA Br J Pharmacol; 2004 Mar; 141(6):971-8. PubMed ID: 14993107 [TBL] [Abstract][Full Text] [Related]
3. LRP and alphavbeta3 mediate tPA activation of smooth muscle cells. Akkawi S; Nassar T; Tarshis M; Cines DB; Higazi AA Am J Physiol Heart Circ Physiol; 2006 Sep; 291(3):H1351-9. PubMed ID: 16489109 [TBL] [Abstract][Full Text] [Related]
4. The pro- or antiangiogenic effect of plasminogen activator inhibitor 1 is dose dependent. Devy L; Blacher S; Grignet-Debrus C; Bajou K; Masson V; Gerard RD; Gils A; Carmeliet G; Carmeliet P; Declerck PJ; Nöel A; Foidart JM FASEB J; 2002 Feb; 16(2):147-54. PubMed ID: 11818362 [TBL] [Abstract][Full Text] [Related]
5. Plasmin-dependent and -independent effects of plasminogen activators and inhibitor-1 on ex vivo angiogenesis. Brodsky S; Chen J; Lee A; Akassoglou K; Norman J; Goligorsky MS Am J Physiol Heart Circ Physiol; 2001 Oct; 281(4):H1784-92. PubMed ID: 11557572 [TBL] [Abstract][Full Text] [Related]
13. Binding of urokinase to low density lipoprotein-related receptor (LRP) regulates vascular smooth muscle cell contraction. Nassar T; Haj-Yehia A; Akkawi S; Kuo A; Bdeir K; Mazar A; Cines DB; Higazi AA J Biol Chem; 2002 Oct; 277(43):40499-504. PubMed ID: 12171938 [TBL] [Abstract][Full Text] [Related]
14. Regulation of tissue plasminogen activator/plasminogen activator inhibitor-1 by hydrocortisone in rat primary astrocytes. Kwon KJ; Cho KS; Lee SH; Kim JN; Joo SH; Ryu JH; Ignarro LJ; Han SH; Shin CY J Neurosci Res; 2011 Jul; 89(7):1059-69. PubMed ID: 21412817 [TBL] [Abstract][Full Text] [Related]
15. Plasminogen Activator Inhibitor-1 Reduces Tissue-Type Plasminogen Activator-Dependent Fibrinolysis and Intrahepatic Hemorrhage in Experimental Acetaminophen Overdose. Pant A; Kopec AK; Baker KS; Cline-Fedewa H; Lawrence DA; Luyendyk JP Am J Pathol; 2018 May; 188(5):1204-1212. PubMed ID: 29454747 [TBL] [Abstract][Full Text] [Related]
16. The variable region-1 from tissue-type plasminogen activator confers specificity for plasminogen activator inhibitor-1 to thrombin by facilitating catalysis: release of a kinetic block by a heterologous protein surface loop. Dekker RJ; Eichinger A; Stoop AA; Bode W; Pannekoek H; Horrevoets AJ J Mol Biol; 1999 Oct; 293(3):613-27. PubMed ID: 10543954 [TBL] [Abstract][Full Text] [Related]
17. Plasminogen activator inhibitor-1 is a major determinant of arterial thrombolysis resistance. Zhu Y; Carmeliet P; Fay WP Circulation; 1999 Jun; 99(23):3050-5. PubMed ID: 10368124 [TBL] [Abstract][Full Text] [Related]
18. Localization and regulation of the tissue plasminogen activator-plasmin system in the hippocampus. Salles FJ; Strickland S J Neurosci; 2002 Mar; 22(6):2125-34. PubMed ID: 11896152 [TBL] [Abstract][Full Text] [Related]
19. Role of tissue plasminogen activator receptor LRP in hippocampal long-term potentiation. Zhuo M; Holtzman DM; Li Y; Osaka H; DeMaro J; Jacquin M; Bu G J Neurosci; 2000 Jan; 20(2):542-9. PubMed ID: 10632583 [TBL] [Abstract][Full Text] [Related]
20. The role of the fibrinolytic system in corneal angiogenesis. Vogten JM; Reijerkerk A; Meijers JC; Voest EE; Borel Rinkes IH; Gebbink MF Angiogenesis; 2003; 6(4):311-6. PubMed ID: 15166500 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]